September 14, 2025 - 19:04

Earlier this week, Workday announced that Voya Financial has been designated as a Strategic Workday Wellness Partner for Health. This partnership will integrate Voya’s Employee Benefit Supplemental Health and Retirement solutions with Workday Wellness, creating a more robust and AI-powered benefits administration system for both employers and employees.
This collaboration represents a significant advancement for Voya as it seeks to align its workplace benefits strategy with innovative digital tools and actionable insights. By leveraging artificial intelligence, the partnership aims to enhance the personalization of employee benefits, making them more tailored to individual needs.
The integration is expected to streamline the benefits administration process, allowing employers to provide more comprehensive and user-friendly options for their workforce. As companies increasingly prioritize employee wellness and satisfaction, this strategic alliance positions Voya Financial at the forefront of the evolving landscape of workplace benefits. The move could potentially redefine how benefits are managed and delivered in the corporate world.
November 11, 2026 - 03:35
Resideo Reports Third Quarter 2026 Financial Performance and Outlook UpdateResideo Technologies, Inc. has shared its financial results for the third quarter of 2026, which concluded on October 3. The company, known for its innovative control and sensing solutions in the...
November 10, 2026 - 13:34
Hong Kong's Financial Transformation: China Aims for Global InfluenceA recent report explores how Beijing is reshaping Hong Kong into a key player in the global financial landscape. The analysis, conducted by ASPI`s Center for China Analysis and Enodo Economics,...
November 10, 2026 - 09:52
BitGo Holdings Reports Significant Revenue Decline in Q3BitGo Holdings, known by the ticker BTGO, has revealed a troubling 50.9% drop in year-over-year revenue for the third quarter. The decline is largely attributed to a slowdown in digital asset...
November 9, 2026 - 21:06
New Drug Application Submitted for Azetukalner in Focal SeizuresIn September 2026, a New Drug Application for azetukalner, a treatment for focal seizures, was submitted to the U.S. Food and Drug Administration. This marks a significant step forward in expanding...